Fundraising

Hollencrest Capital Management pulls in $3.25 mln for initial venture fund

Hollencrest Capital Management has raised $3.25 million for its debut venture fund, according to an SEC filing. Based in Newport Beach, California, Hollencrest Capital Management is an investment adviser.

Brightspark raises $6 mln in Kensington-led investment

Canadian early-stage venture capital firm Brightspark has raised $6 million in a round led by Kensington Capital Partners, a Canadian alternative investment firm. The proceeds will be used to advance Brightspark's investment model, launched in 2014, which leverages a network of more than 2,000 accredited investors. The firm said it expects to double the size of its team and increase its investment pace from the equivalent of a traditional $100 million fund to a $120 million fund, with deployments of $20 million to $30 million per year. Founded in 1999, Brightspark is led by Managing Partners Mark Skapinker and Sophie Forest.

Yaletown ups emerging-growth fund's target with C$100 mln first close

Yaletown ups emerging-growth fund's target with $100 mln first close

Yaletown Partners raised more than $100 million in initial commitments for its emerging-growth tech fund, encouraging the firm to bump up the pool's target, two people familiar with the matter told PE Hub Canada. Yaletown Innovation Growth Fund secured the capital in a first close in November, the sources said. It was anchored by a mix of new and returning limited partners, both domestic and international. With strong LP demand, the Vancouver firm adjusted the fund's original goal, the sources said. Yaletown is now seeking a minimum of $175 million and may go as high as $200 million if demand is sustained.

Sama Fund to raise $150 mln venture fund

Sama Fund has set out to raise a $150 million venture fund, according to a filling with the SEC.

Suster, Senkut, Lynn look ahead to 2018

AmorChem closes second early-stage biotech fund at $44.2 mln

AmorChem Group has launched AmorChem II Fund LP, a seed-stage biotechnology investor, at an initial capitalization of $44.2 million. The fund secured commitments from the Québec government, Fonds de solidarité FTQ, U.S. pharmaceutical giant Merck and other limited partners. AmorChem, which now manages $86 million, invests in promising life sciences projects originating from Québec universities and research centres that can be built into startups able to attract investors and pharmaceutical partners. The Montréal investor is led by General Partners Elizabeth Douville and Inès Holzbaur. A new general partner, Maxime Ranger, joined with Fund II's launch.

Viola amasses $100 mln for fintech fund

Israel-based tech investor Viola has raised $100 million for its new global fintech fund. The target is $120 million to $150 million. The fund's backers include Scotiabank, The Travelers Companies Inc and Bank Hapoalim.

Anzu Partners raises $128.4 mln for maiden fund

Anzu Partners has closed its inaugural fund at $128.4 million. Anzu Industrial Capital Partners LP will invest in American and Canadian private industrial technology companies. The fund's limited partners include institutions, family offices and individuals in the U.S. and overseas.

AmorChem collects $44.2 mln for second fund

Montreal-based AmorChem, a life sciences venture firm, has raised $44.2 million for its second fund. AmorChem II will focus on backing "promising" life science projects originating from Québec-based universities and research centers. The fund's limited partners include the Québec government, Fonds de solidarité FTQ and Merck.